- Authors
Hélène Goussault, Sébastien Gendarme, Jean-Baptiste Assié, Camille Jung, Salomé Epaud, Christelle Algans, Noémie Salaun-Penquer, Mathilde Rousseau, Andrea Lazatti, Christos Chouaïd
*Author details available on the publication
- reference
PMID: 35567378 / DOI: 10.1002/cam4.4821
Despite therapeutic advances, lung cancer remains the first cause of death from cancer. The main objective of this study was to identify risk factors associated with death within 3- months of the first hospitalization for lung cancer in France
Almost 1 in 5 patients diagnosed with lung cancer in France died within 3 months post- diagnosis. Improving survival requires diagnosis at an ear-lier stage and better organization of diagnosis and specific care pathways.
Other resources you may be interested in
A Prospective Pharmacoepidemiologic Cohort Study in 30 French NICUs From 2014 to 2020
No consensus exists about the doses of analgesics, sedatives, anesthetics, and paralytics used in critically ill neonates.
Comparison of explanatory methods: influence of characteristics
Kaduceo, co-author of work presented at the 24th International Workshop on Design, Optimization, Languages and Analytical Processing of Big Data